The kind of supercycle we saw in the previous decade can't be replicated in next 5-10 years as it depended on huge demand from China, says ...

In her home state Massachusetts, she does medical marijuana authorisations and is involved in efforts to reform US government policy on mar...

“As economic activity picks up and earnings pick up into the second half of this year and next year, you should see good returns from the m...

Inside the collaborative world of co-working, the benefits it’s yielding start-ups and why a clutch of entrepreneurs is ramping up such spa...

US cos such as Honeywell & Boeing, & professors of US universities have backed India before the USTR that is currently assessing country’s ...

Conventional wisdom suggests that healthcare sector is recession proof and does not necessarily mirror the lows and highs of the economy.

Under an agreement, drug regulators of member countries ensure compliance with standards rather than individual manufacturers.

Pharmaceutical preparations containing narcotic drugs continue to be diverted from Indian pharma firms and smuggled into South Asian countr...

Aditya Birla Group, TAS, Mahindra and Reliance were among the conglomerates which recruited students for their flagship management leadersh...

India has the potential to become a leading global player for stem cell products and services. So, the government must act fast in implemen...

Sectors which have dollar revenues like technology, pharma and some auto components will be outperformers.

The Central Government will soon set up a National Institute of Pharmaceutical Education and Research (NIPER) in Odisha.

Startups are flourishing again thanks to capital, talent & mentors backing smart ideas but it's still early to say startups have got their ...

Startups are flourishing again thanks to capital, talent & mentors backing smart ideas but it's still early to say startups have got their ...

ET Intelligence Group identified the next lot of companies who have the potential to make it to the ET 500 club next year.

The global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.

Indian and US businessmen are finding a lot of common ground in pursuing’s business ventures in each other s countries.